Arena Pharmaceuticals (ARNA) Posts Mixed Q1 Results
Tweet Send to a FriendGet Alerts ARNA Hot Sheet
Trade ARNA Now!
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported Q1 EPS of ($0.35), $0.14 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $3.92 million versus the consensus estimate of $3.29 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Synopsys, Inc. (SNPS) Tops Q1 EPS by 3c, Offers Guidance
- China Digital TV Holding Co. (STV) Improves Q1 EPS to 13c
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
